7600 Ultrasound System (MyLabC25) vs SCENARIA View Phase

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by FUJIFILM Corporation

AI Verdict

Tool A is a portable AI-powered ultrasound system, best suited for real-time imaging across general, cardiac, and women's health applications, emphasizing versatility and mobility. In contrast, Tool B is an AI-powered CT system designed for advanced diagnostic radiology, offering significant dose reduction and specialized features for cardiac imaging and oncology screenings. While both leverage AI in radiology and cardiology, their distinct imaging modalities and specific feature sets cater to different diagnostic requirements.

Choose 7600 Ultrasound System (MyLabC25) if…

Choose the Esaote MyLab™C25 if your clinical practice requires a highly portable and versatile ultrasound solution for point-of-care diagnostics or mobile healthcare settings. Its compact design, long-lasting battery, and AI-powered functions make it ideal for quick, on-the-go assessments across general imaging, cardiology, and women's health specialties.

View 7600 Ultrasound System (MyLabC25) →

Choose SCENARIA View Phase if…

Choose the FUJIFILM SCENARIA View Phase if your facility needs a high-performance, fixed-site CT system capable of advanced diagnostic radiology with a strong emphasis on dose reduction and patient comfort. This system is particularly well-suited for comprehensive cardiac imaging, low-dose lung cancer screening, and general radiology where detailed cross-sectional images are critical.

View SCENARIA View Phase →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature 7600 Ultrasound System (MyLabC25) SCENARIA View Phase
Pricing Unknown Contact for pricing
Deployment On-premise (portable system) On-premise
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

7600 Ultrasound System (MyLabC25)

Tool A, the Esaote MyLabu2122C25, emphasizes direct user interaction with its portable design, tiltable and ultrawide touchscreens, and an easy-to-clean control panel, making it highly adaptable for various clinical environments and rapid access to ultrasound. While Tool B focuses on patient comfort and automated setup, Tool A's features provide greater flexibility and intuitive interaction for the operator during scanning.

Clinical Value

SCENARIA View Phase

Tool B, the FUJIFILM SCENARIA View Phase, offers superior clinical value through specific, quantifiable advancements like up to 83% dose reduction with AI-based iterative reconstruction and 28ms effective temporal resolution for cardiac CT with Cardio StillShot. These features directly enhance patient safety and diagnostic accuracy in critical areas. Tool A's AI enhancements for ultrasound are described more generally, lacking the detailed, impactful clinical outcomes of Tool B.

Pricing & Value

Tie

Both tools operate on an enterprise sales model, requiring direct contact for pricing, which limits transparency. While third-party marketplaces provided some price indications for both, these are not official or consistently available, making a direct comparison of their pricing and overall value proposition difficult.

Enterprise Readiness

SCENARIA View Phase

Both tools are FDA cleared, HIPAA compliant, and on-premise. However, Tool B explicitly states a Business Associate Agreement (BAA) and compliance with NEMA XR-25 and XR-29 for dose reporting, alongside SYNAPSE 3D integration for advanced analysis. These details indicate a more robust and documented framework for enterprise-level data management, compliance, and integration within a larger imaging ecosystem.

Innovation

SCENARIA View Phase

Tool B demonstrates a higher degree of innovation by integrating advanced AI directly into the core CT imaging process, delivering groundbreaking improvements in dose reduction, cardiac motion correction, and metal artifact suppression. These are fundamental advancements in CT technology. While Tool A offers innovative portability and user interface for ultrasound, Tool B's specific AI-driven clinical breakthroughs represent a more significant leap in imaging capability.

Support & Docs

SCENARIA View Phase

Both companies offer extensive documentation and support. However, Fujifilm (Tool B) explicitly provides a Learning Management System (LMS) for service training and 24/7 technical support, indicating a comprehensive and structured approach to ongoing support and education for their complex CT systems. Esaote (Tool A) also offers various clinical and technical documentation, but Fujifilm's offerings appear more detailed and structured for enterprise-level service and training.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature 7600 Ultrasound System (MyLabC25) SCENARIA View Phase
Product Name 7600 Ultrasound System (MyLabC25) SCENARIA View Phase
Company Esaote FUJIFILM Corporation
Product Type Portable Ultrasound System AI-powered CT system
Primary AI Focus Workflow optimization and image enhancement Dose reduction, motion correction, automatic positioning
Key Feature (Portability/Dose Reduction) Portable and compact design; long-lasting battery (up to 5 hours) AI-based iterative reconstruction (Intelli IPV) for up to 83% dose reduction
Key Feature (Interface/Cardiac Specific) Tiltable 15.6'' main screen; Ultrawide 15'' touchscreen with digital TGC Cardio StillShot for motion correction in cardiac CT (28ms effective temporal resolution)
Specialties Cardiology, Obstetrics & Gynecology, Radiology Cardiology, Oncology, Radiology

Videos

Demos, reviews, and walkthroughs featuring 7600 Ultrasound System (MyLabC25) and SCENARIA View Phase.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tool A, the Esaote MyLabu2122C25, is a portable ultrasound system. Tool B, the FUJIFILM SCENARIA View Phase, is an AI-powered CT system.
Tool A's AI-powered functions are for enhanced diagnostic imaging and workflow optimization. Tool B utilizes AI for advanced imaging, significant dose reduction (up to 83% with Intelli IPV), streamlined workflows, automatic scan range setting (AutoPose AI), and motion correction in cardiac CT (Cardio StillShot).
Tool A is designed for general imaging, cardiology, and women's health (Obstetrics & Gynecology, Radiology). Tool B is suited for comprehensive diagnostic radiology, including cardiac, oncology, and low-dose lung cancer screening.
The SCENARIA View Phase CT system offers AI-based iterative reconstruction (Intelli IPV) for up to 83% dose reduction, DICOM Dose Structured Report, and Dose Check (NEMA XR-25 compliant). For patient comfort, it features a wide 80cm gantry aperture and a 550lbs (250kg) table weight capacity, along with an Auto Lateral Shift Table for precise patient positioning.
Both systems support cardiology. Tool A is a portable ultrasound system for cardiology applications. Tool B, the SCENARIA View Phase CT system, offers specific cardiac features like Cardio StillShot for motion correction, achieving 28ms effective temporal resolution, and is used for cardiac CT angiography (CCTA).
Tool A includes networking features for data management and sharing. Tool B offers DICOM Dose Structured Report and Dose Check, and integrates with SYNAPSE 3D for advanced image analysis and automatic organ segmentation.
AI Tool Finder
AI-powered search. Results may not be comprehensive.